Roy A. Raad

Biosketch / Results /

Roy Raad

Assistant Professor, Department of Radiology

Contact Info

Address
160 East 34th Street
New York, NY 10016


Comparison of Whole-Body F FDG PET/MR Imaging and Whole-Body F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer
Melsaether, Amy N; Raad, Roy A; Pujara, Akshat C; Ponzo, Fabio D; Pysarenko, Kristine M; Jhaveri, Komal; Babb, James S; Sigmund, Eric E; Kim, Sungheon G; Moy, Linda A. Comparison of Whole-Body F FDG PET/MR Imaging and Whole-Body F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer. Radiology. 2016 Mar 29;:151155-151155 (2059122)

Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT
Pujara, Akshat C; Raad, Roy A; Ponzo, Fabio; Wassong, Carolyn; Babb, James S; Moy, Linda; Melsaether, Amy N. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT. Breast journal. 2016 Feb 4;22(3):264-273 (1933142)

Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging
Sacconi, B; Raad, R A; Lee, J; Fine, H; Kondziolka, D; Golfinos, J G; Babb, J S; Jain, R. Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging. Journal of neuro-oncology. 2016 Jan 4;127(2):287-293 (1901082)

Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?
Silverton, Alexandra; Raad, Roy A; Katz, Leah; Downey, Andrea; Muggia, Franco M. Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?. ecancermedicalscience. 2016 ;10:646-646 (2165562)

Imaging and evaluation of patients with high-risk prostate cancer
Bjurlin, Marc A; Rosenkrantz, Andrew B; Beltran, Luis S; Raad, Roy A; Taneja, Samir S. Imaging and evaluation of patients with high-risk prostate cancer. Nature reviews. Urology. 2015 Oct 20;12(11):617-628 (1810402)